Quarterly report pursuant to Section 13 or 15(d)

SHARE-BASED COMPENSATION AND WARRANTS

v3.22.0.1
SHARE-BASED COMPENSATION AND WARRANTS
6 Months Ended
Dec. 31, 2021
SHARE-BASED COMPENSATION AND WARRANTS  
SHARE-BASED COMPENSATION AND WARRANTS

NOTE 7 — SHARE-BASED COMPENSATION AND WARRANTS

Stock Option Plans

Presented below is a summary of the number of shares authorized, outstanding, and available for future grants under each of the Company’s stock option plans as of December 31, 2021 (in thousands):

Termination

Number of Shares

Description

    

Date

    

Authorized

    

Outstanding

    

Available

2015 Plan

 

February 2020

 

50

 

50

 

2016 Plan

 

October 2021

 

260

 

260

 

2019 Plan

 

July 2029

 

200

 

200

 

2021 Plan

 

March 2030

 

1,200

 

797

 

403

Total

 

  

 

1,710

 

1,307

 

403

Stock Options Outstanding

The following table sets forth a summary of the stock option activity under all of the Company’s stock option plans for the six months ended December 31, 2021 (shares in thousands):

    

Shares

    

Price (1)

    

Term (2)

Outstanding, June 30, 2021

 

1,285

$

16.35

 

8.7

Granted

 

109

 

7.69

 

Forfeited

(87)

19.33

Outstanding, December 31, 2021

 

1,307

 

15.43

 

8.6

Vested, December 31, 2021

 

541

 

20.13

 

7.8

(1) Represents the weighted average exercise price.
(2) Represents the weighted average remaining contractual term for the number of years until the stock options expire.

For the six months ended December 31, 2021, the aggregate fair value of stock options granted for approximately 0.1 million shares of common stock that provide solely for time-based vesting, amounted to $0.6 million or approximately $5.72 per share as of the grant dates. Fair value was computed using the BSM option-pricing model and will result in the recognition of compensation cost ratably over the expected vesting period of the stock options. For the six months ended December 31, 2021, the fair value of stock options was estimated on the date of grant, with the following weighted-average assumptions:

Market price of common stock on grant date

   

$

7.69

Expected volatility

 

90

%

Risk free interest rate

 

1.1

%

Expected term (years)

 

6.1

Dividend yield

 

0

%

Share-based compensation expense for the three and six months ended December 31, 2021 and 2020 is included under the following captions in the unaudited condensed consolidated statements of operations (in thousands):

Three Months Ended

Six Months Ended

December 31, 

December 31, 

    

2021

    

2020

    

2021

    

2020

Research and development

$

378

$

493

$

687

$

814

General and administrative

 

631

 

648

 

1,164

 

961

Total

$

1,009

$

1,141

$

1,851

$

1,775

Unrecognized share-based compensation expense is approximately $6.9 million as of December 31, 2021. This amount is expected to be recognized over a weighted average period of 2.4 years.

Warrants

In connection with the Underwritten Offering discussed in Note 6, the Company issued 1,661,461 Pre-Funded Warrants to purchase 1,661,461 shares of common stock at an issuance price of $6.49 per warrant for gross proceeds of $10.8 million. The Pre-Funded Warrants may be exercised at any time by paying the exercise price of $0.01 per share, subject to the terms discussed in Note 6.

In addition, the Company has issued warrants in conjunction with various debt and equity financings and for services. The following table sets forth a summary of the warrant activity (excluding the Pre-Funded Warrants) for the six months ended December 31, 2021 (shares in thousands):

    

Shares

    

Price(1)

    

Term(2)

Outstanding, June 30, 2021

 

1,252

$

28.91

 

4.8

Warrants expired

(65)

82.50

Outstanding, December 31, 2021

 

1,187

 

25.97

 

4.5

(1) Represents the weighted average exercise price.
(2) Represents the weighted average remaining contractual term for the number of years until the warrants expire.